remifentanil has been researched along with Endometrial Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XH; Ni, Y; Zhang, SB; Zhu, LJ | 1 |
| Francés, RC; Gascón, AH; Hernando, AN; Lobera, JC; Valién, JL | 1 |
2 trial(s) available for remifentanil and Endometrial Neoplasms
| Article | Year |
|---|---|
Remifentanil injected during analepsia shortens length of postanesthesia care unit stay in patients undergoing laparoscopic surgery for endometrial cancer: a randomized controlled trial.
Topics: Anesthetics, Intravenous; Endometrial Neoplasms; Female; Humans; Laparoscopy; Piperidines; Prospective Studies; Remifentanil | 2021 |
[Cellular immune response to 3 anesthetic techniques for simple abdominal hysterectomy].
Topics: Adenocarcinoma; Analgesia; Analgesia, Epidural; Analgesics; Anesthesia, Epidural; Anesthesia, General; Anesthetics, General; Endometrial Neoplasms; Female; Fentanyl; Humans; Hysterectomy; Immunologic Surveillance; Killer Cells, Natural; Lymphocyte Subsets; Lymphopenia; Methyl Ethers; Middle Aged; Morphine; Piperidines; Postoperative Complications; Prospective Studies; Remifentanil; Sevoflurane | 2007 |